Results 231 to 240 of about 824,404 (357)

Correction: Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund Support

Harm Reduction Journal
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak   +3 more
doaj   +1 more source

The place of supervised injecting facilities within harm reduction: evidence, ethics and policy

, 2006
Craig Fry, Stefan Cvetkovski, Jacqui Cameron   +2 more
openalex   +1 more source

The E3 ubiquitin ligase, RNF219, suppresses CNOT6L expression to exhibit antiproliferative activity

FEBS Open Bio, EarlyView.
We identified RNF219 as a CCR4‐NOT complex‐interacting E3 ubiquitin ligase that targets the CCR4‐NOT subunit CNOT6L for ubiquitination. RNF219 directly binds to the DUF3819 domain of CNOT1 through its putative α‐helix spanning amino acids 521–542. Our findings also suggest that antiproliferative activity of RNF219 is at least partially mediated by ...
Shou Soeda, Melissa Montrose, Akinori Takahashi, Risa Ishida, Sandrine Burriel, Nao Ohmine, Tohru Natsume, Shungo Adachi, Minsoo Kim, Tadashi Yamamoto   +9 more
wiley   +1 more source

Public Health Implications of Smokeless Tobacco Use as a Harm Reduction Strategy

, 2006
David A. Savitz, Roger E. Meyer, J.M. Tanzer, Sidney S. Mirvish, Freddi Lewin   +4 more
openalex   +2 more sources

Harm reduction for injecting opiate users: an update and implications in China [PDF]

, 2009
Maja Meise, Xi Wang, Marie-Luise Sauter, Yanping Bao, Jie Shi, Zhimin Liu, Lin Lü   +6 more
openalex   +1 more source

Actin dynamics controlled by IqgC, a RasGAP at the crossroads between the IQGAP and fungal GAP1 families

FEBS Open Bio, EarlyView.
IqgC is a RasGAP from Dictyostelium discoideum. IqgC binds RasG via its RasGAP domain and deactivates it on macroendocytic cups, thereby suppressing the uptake of fluid and particles. IqgC has a positive effect on cell‐substratum adhesion, and its RGCt domain is required for recruitment to ventral foci.
Vedrana Filić, Darija Putar, Lucija Mijanović, Igor Weber   +3 more
wiley   +1 more source

Colonial harm in new packaging: Indigenous critiques of the tobacco industry's 'harm reduction' rhetoric. [PDF]

Health Promot Int
Maddox R, Heris C, Waa A, Teddy L, Upton P, Henderson PN, Kornacki C, Rodriguez J, Lee J, Tautolo ES, Martinez SA, Bradbrook SK, Kennedy M.   +12 more
europepmc   +1 more source

Two‐way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3

FEBS Open Bio, EarlyView.
PAX5::CBFA2T3 (PAX5‐C) is a fusion protein of the B‐cell transcription factor, PAX5, and is found in B‐cell ALL. We propose a putative model of two‐way inhibition of PAX5 transcriptional activity by PAX5‐C. There are two ways of repression by PAX5‐C: DNA‐binding‐dependent way and HDAC‐dependent way, with either being sufficient for the repression. HDAC
Reina Ueno, Aki Terasaki, Yuiko Imai, Yuri Kimura, Yuna Kojima, Misa Irie, Koya Odaira, Mina Noura, Shuichi Okamoto, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa   +12 more
wiley   +1 more source

Barriers and recommendations for harm reduction services among people living with HIV in Manitoba, Canada: a qualitative study. [PDF]

Front Public Health
Villacis-Alvarez E, Maier K, Haworth-Brockman M, Pashe H, Baliddawa J, Daniels N, Murdock R, Russell R, Dan C, Woodhouse F, Cusson S, Schenkels M, Kasper K, MacKenzie LJ, Ireland L, Templeton K, Keynan Y, Rueda ZV.   +17 more
europepmc   +1 more source

Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm [PDF]

, 2009
Renate Quinzler, S. P. W. Schmitt, Maria Pritsch, Jens Kaltschmidt, Walter E. Haefeli   +4 more
openalex   +1 more source